All six anti-MDA5 antibody-positive patients with DM with RP-ILD had hypoxemia (partial arterial pressure of oxygen (PaO2)/fraction of inspired oxygen (FiO2) ratio ≤ 200) before starting intensive therapy and their disease duration was 1.2 ± 0.4 months. The gene discussed is IFIH1; the disease is dermatomyositis.